Fate Therapeutics Inc - Company Profile

Powered by

All the data and insights you need on Fate Therapeutics Inc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Fate Therapeutics Inc Strategy Report

  • Understand Fate Therapeutics Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Fate Therapeutics Inc: Overview

Select Item

Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline includes various off-the-shelf, iPSC-derived cellular immunotherapies for the treatment of several hematological malignancies and advanced solid tumors. Its pipeline products also include a donor-derived cell product candidate for the treatment of hematological malignancies. Fate uses its proprietary human-induced pluripotent stem cell (iPSC) platform for product development. The company also has research collaborations with companies, academic centers and medical centers for the advancement of products and technologies. Fate Therapeutics is headquartered in San Diego, California, the US.

 Gain a 360-degree view of Fate Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Fate Therapeutics Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 12278 Scripps Summit Drive, San Diego, California, 92131
Website fatetherapeutics.com
Telephone 1 858 8751803
No of Employees 181
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange FATE (NASD)
Revenue (2022) $63.5M -34% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 42.9% (2022 vs 2021)
Market Cap* $596.4M
Net Profit Margin (2022) XYZ 13.4% (2022 vs 2021)
* As of and is in US$
View Fate Therapeutics Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Fate Therapeutics Inc premium industry data and analytics

50+

Catalyst Calendar

Proactively evaluate Fate Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

30+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Fate Therapeutics Inc’s relevant decision makers and contact details.

30+

Pipeline Drugs

Identify which of Fate Therapeutics Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Clinical Trials

Determine Fate Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

8

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

6

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products
Pipeline:
Off-the-shelf, iPSC-derived Cellular Immunotherapies:
FT819 for B-cell Malignancies and Chronic Lymphocytic Leukemia
XYZ
XYZ
XYZ
Understand Fate Therapeutics Inc portfolio and identify potential areas for collaboration Understand Fate Therapeutics Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Fate Therapeutics Inc Johnson & Johnson Sanofi Novartis AG Bristol-Myers Squibb Co
Headquarters United States of America United States of America France Switzerland United States of America
City San Diego New Brunswick Paris Basel Princeton
State/Province California New Jersey Ile-de-France - New Jersey
No. of Employees 181 131,900 87,994 76,057 34,100
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
William Rastetter, Ph.D. Chairman Executive Board 2011 74
J. Scott Wolchko President; Chief Executive Officer; Director Executive Board 2015 52
Edward Dulac Chief Financial Officer Senior Management 2020 48
Mark Plavsic Chief Technology Officer Senior Management 2021 -
Yu-Waye (Wayne) Chu, M.D. Chief Medical Officer Senior Management 2022 55
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Fate Therapeutics Inc key executives to enhance your sales strategy Gain insight into Fate Therapeutics Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward